Similar articles for PMID: 23468489

Year	Number of Results
1966	1
1986	1
1992	1
1995	2
1996	3
1998	1
2001	1
2005	1
2006	1
2007	4
2008	1
2009	6
2010	3
2011	4
2012	6
2013	9
2014	8
2015	2
2016	5
2017	6
2018	3
2019	2
2020	2
2021	0

1

Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for FcγR2a and FcγR2b.

Ackerman ME, Dugast AS, McAndrew EG, Tsoukas S, Licht AF, Irvine DJ, Alter G. Ackerman ME, et al. J Virol. 2013 May;87(10):5468-76. doi: 10.1128/JVI.03403-12. Epub 2013 Mar 6. J Virol. 2013. PMID: 23468489 Free PMC article.

2

Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.

Brown EP, Dowell KG, Boesch AW, Normandin E, Mahan AE, Chu T, Barouch DH, Bailey-Kellogg C, Alter G, Ackerman ME. Brown EP, et al. J Immunol Methods. 2017 Apr;443:33-44. doi: 10.1016/j.jim.2017.01.010. Epub 2017 Feb 3. J Immunol Methods. 2017. PMID: 28163018 Free PMC article.

3

Anti-retroviral antibody FcγR-mediated effector functions.

Bournazos S, Ravetch JV. Bournazos S, et al. Immunol Rev. 2017 Jan;275(1):285-295. doi: 10.1111/imr.12482. Immunol Rev. 2017. PMID: 28133801 Free PMC article. Review.

4

Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.

Wines BD, Billings H, Mclean MR, Kent SJ, Hogarth PM. Wines BD, et al. Curr HIV Res. 2017;15(3):202-215. doi: 10.2174/1570162X15666170320112247. Curr HIV Res. 2017. PMID: 28322167 Free PMC article. Review.

5

Divergent antibody subclass and specificity profiles but not protective HLA-B alleles are associated with variable antibody effector function among HIV-1 controllers.

Lai JI, Licht AF, Dugast AS, Suscovich T, Choi I, Bailey-Kellogg C, Alter G, Ackerman ME. Lai JI, et al. J Virol. 2014 Mar;88(5):2799-809. doi: 10.1128/JVI.03130-13. Epub 2013 Dec 18. J Virol. 2014. PMID: 24352471 Free PMC article.

6

Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination.

Mahan AE, Jennewein MF, Suscovich T, Dionne K, Tedesco J, Chung AW, Streeck H, Pau M, Schuitemaker H, Francis D, Fast P, Laufer D, Walker BD, Baden L, Barouch DH, Alter G. Mahan AE, et al. PLoS Pathog. 2016 Mar 16;12(3):e1005456. doi: 10.1371/journal.ppat.1005456. eCollection 2016 Mar. PLoS Pathog. 2016. PMID: 26982805 Free PMC article.

7

Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity.

Ackerman ME, Crispin M, Yu X, Baruah K, Boesch AW, Harvey DJ, Dugast AS, Heizen EL, Ercan A, Choi I, Streeck H, Nigrovic PA, Bailey-Kellogg C, Scanlan C, Alter G. Ackerman ME, et al. J Clin Invest. 2013 May;123(5):2183-92. doi: 10.1172/JCI65708. Epub 2013 Apr 8. J Clin Invest. 2013. PMID: 23563315 Free PMC article.

8

Determining the phagocytic activity of clinical antibody samples.

McAndrew EG, Dugast AS, Licht AF, Eusebio JR, Alter G, Ackerman ME. McAndrew EG, et al. J Vis Exp. 2011 Nov 30;(57):e3588. doi: 10.3791/3588. J Vis Exp. 2011. PMID: 22143444 Free PMC article.

9

Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention.

Vargas-Inchaustegui DA, Robert-Guroff M. Vargas-Inchaustegui DA, et al. Curr HIV Res. 2013 Jul;11(5):407-20. doi: 10.2174/1570162x113116660063. Curr HIV Res. 2013. PMID: 24191937 Free PMC article.

10

A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples.

Ackerman ME, Moldt B, Wyatt RT, Dugast AS, McAndrew E, Tsoukas S, Jost S, Berger CT, Sciaranghella G, Liu Q, Irvine DJ, Burton DR, Alter G. Ackerman ME, et al. J Immunol Methods. 2011 Mar 7;366(1-2):8-19. doi: 10.1016/j.jim.2010.12.016. Epub 2010 Dec 27. J Immunol Methods. 2011. PMID: 21192942 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed